title: Quantitative evaluation of renal parenchymal mass with 99mtechnetium dimercapto-succinic acid scintigraphy after nephrolithotomy.
abstract: OBJECTIVE
  We detected renal parenchymal damage after nephrolithotomy.
  
  
  METHODS
  We studied 12 patients with renal stones treated with nephrolithotomy. Renal function was determined with serum blood urea nitrogen (BUN) and creatinine values, and 99mtechnetium dimercapto-succinic acid scintigraphy of renal parenchymal tissue was performed before, and 7 days and 3 months after nephrolithotomy. Qualitative and quantitative analyses were done with the Wilcoxon signed rank test.
  
  
  RESULTS
  There was no visual difference in size and appearance of the nephrotomy site between preoperative and postoperative visual scintigraphic evaluations. Quantitative data did not reveal any significant difference between kidneys with and without a nephrotomy incision (p > 0.05), as well as between nephrotomy regions and intact parenchyma within the same kidney (p > 0.05) 3 months after nephrolithotomy. There was no significant difference in serum BUN and creatinine levels between values preoperatively and 3 months postoperatively (p > 0.05).
  
  
  CONCLUSIONS
  There was no significant change in renal cortical function and functioning renal parenchymal mass after nephrolithotomy as shown by serum BUN and creatinine levels, and 99mtechnetium dimercapto-succinic acid scintigraphy.
authors.affiliation: Department of Urology, Hacettepe University, School of Medicine, Ankara, Turkey.
authors.forename: M D
authors.initials: MD
authors.lastname: Balbay
authors.forename: E
authors.initials: E
authors.lastname: Varoğlu
authors.forename: H
authors.initials: H
authors.lastname: Devrim
authors.forename: A
authors.initials: A
authors.lastname: Sahin
authors.forename: A
authors.initials: A
authors.lastname: Atan
authors.forename: A
authors.initials: A
authors.lastname: Ergen
authors.forename: D
authors.initials: D
authors.lastname: Remzi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006801:Humans; D007668:Kidney / Q000000981:diagnostic imaging*; D007669:Kidney Calculi / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009403:Nephrostomy, Percutaneous / Q000009:adverse effects*; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D011446:Prospective Studies; D011877:Radionuclide Imaging; D004113:Succimer / Q000493:pharmacokinetics; D019783:Technetium Tc 99m Dimercaptosuccinic Acid
chemical_list: D015609:Organotechnetium Compounds; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D004113:Succimer